Evidence map›Paper›PMID 36730207›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2023

Distinctive transcriptomic and epigenomic signatures of bone marrow-derived myeloid cells and microglia in CNS autoimmunity.

Navid Manouchehri, Victor H Salinas, Rehana Z Hussain, Olaf Stüve

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Navid ManouchehriDepartment of Neurology, University of Texas Southwestern Medical Center, Dallas, TX 75390.ORCID 0000-0001-5773-2622
Victor H SalinasDepartment of Neurology, University of Texas Southwestern Medical Center, Dallas, TX 75390.ORCID 0000-0002-7839-8560
Rehana Z HussainDepartment of Neurology, University of Texas Southwestern Medical Center, Dallas, TX 75390.ORCID 0000-0002-7700-913X
Olaf StüveDepartment of Neurology, University of Texas Southwestern Medical Center, Dallas, TX 75390.ORCID 0000-0002-0469-6872
The University of Texas Southwestern Medical Center · USVA North Texas Health Care System · US

Funding

BLRD VA I01 BX005664
6 · The paper itself

Abstract

In the context of autoimmunity, myeloid cells of the central nervous system (CNS) constitute an ontogenically heterogeneous population that includes yolk sac-derived microglia and infiltrating bone marrow-derived cells (BMC). We previously identified a myeloid cell subset in the brain and spinal cord that expresses the surface markers CD88 and CD317 and is associated with the onset and persistence of clinical disease in the murine model of the human CNS autoimmune disorder, experimental autoimmune encephalomyelitis (EAE). We employed an experimental platform utilizing single-cell transcriptomic and epigenomic profiling of bone marrow-chimeric mice to categorically distinguish BMC from microglia during CNS autoimmunity. Analysis of gene expression and chromosomal accessibility identified CD88

Indexed as

Encephalomyelitis, Autoimmune, ExperimentalMicrogliaAnimalsAutoimmunityBone MarrowCentral Nervous SystemEpigenomicsHumansMiceMice, Inbred C57BLMyeloid CellsTranscriptomeexperimental autoimmune encephalomyelitismicrogliamultiple sclerosismyeloid cellstranscriptomics

Identifiers

PMID36730207
PMCPMC9963604
OpenAlexW4318925869

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.